Biochemical characterization and immunohistochemical localization of urotensin II in the human brainstem and spinal cord

Journal of Neurochemistry
Nicolas ChartrelHubert Vaudry

Abstract

The human urotensin II (UII) precursor encompasses several potential cleavage sites and thus, processing of pro-UII may generate various forms of mature UII including the peptides of 11 (UII11), 16 (UII16) and 19 (UII19) residues. Until now, the native form of human UII had not been characterized. Here, we show that the major UII peptide occurring in the human spinal cord corresponds to UII11. In contrast, neither the UII16 nor the UII19 forms could be detected. In 50% of the brainstem and in all the spinal cord extracts analysed, a second minor UII-immunoreactive peptide was resolved. Immunohistochemical labelling of the cervical segment of the human spinal cord revealed that the UII-immunoreactive material was confined to a subset of ventral horn motoneurones. These data provide the first evidence that in the human, the UII precursor, expressed in motoneurones, is processed at the tribasic KKR93 cleavage site to generate a mature form of UII of 11 amino acids. The absence of N-terminally elongated forms of UII of 16 and 19 residues indicates that pro-UII is not cleaved at the R85 or K88 monobasic sites. Finally, the minor UII-immunoreactive peptide detected in several tissue extracts might correspond to an extended form of UI...Continue Reading

References

Jun 30, 1992·Annals of the New York Academy of Sciences·J P ChangeuxS Sekine
Oct 30, 1992·Biochemical and Biophysical Research Communications·J M ConlonH Vaudry
Jun 18, 1990·FEBS Letters·J M ConlonR J Balment
Feb 1, 1986·Proceedings of the National Academy of Sciences of the United States of America·P FerreroA Guidotti
Aug 1, 1980·Proceedings of the National Academy of Sciences of the United States of America·D PearsonH A Bern
Nov 1, 1980·Proceedings of the National Academy of Sciences of the United States of America·F EschR Guillemin
Jul 1, 1984·General and Comparative Endocrinology·T IchikawaH Kobayashi
Dec 23, 1998·Proceedings of the National Academy of Sciences of the United States of America·Y CoulouarnH Vaudry
Nov 5, 1999·Biochemical and Biophysical Research Communications·M MoriM Fujino
Dec 3, 1999·Biochemical and Biophysical Research Communications·Q LiuC T Caskey
May 18, 2001·Neuroscience Letters·S L DunN J Dun
Sep 21, 2001·Lancet·K TotsuneO Murakami
Jun 22, 2002·Lancet·Stephen A DouglasAdel Giaid
Nov 8, 2002·Journal of Neurochemistry·Catalin M FilipeanuNae J Dun
Jan 11, 2003·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Olfa MasmoudiMarie-Christine Tonon
Feb 26, 2003·Comparative Biochemistry and Physiology. Toxicology & Pharmacology : CBP·Tomokazu KanetohMasaaki Fujimoto
Aug 29, 2003·Journal of Enzyme Inhibition and Medicinal Chemistry·Patricia LabarrèreHubert Vaudry
Oct 11, 2003·Biochemical and Biophysical Research Communications·Tsukasa SugoMasahiko Fujino

❮ Previous
Next ❯

Citations

May 11, 2005·Cardiovascular Drugs and Therapy·Kwok Leung OngBernard M Y Cheung
Dec 1, 2012·Current Opinion in Nephrology and Hypertension·Robyn G Langham, Darren J Kelly
Nov 13, 2012·PloS One·Elena V RomanovaJonathan V Sweedler
Apr 18, 2014·Journal of Molecular Endocrinology·Hervé TostivintDan Larhammar
Sep 15, 2005·Psychopharmacology·Jean-Claude Do-RegoJean Costentin
May 25, 2011·FEBS Letters·Josée BilodeauPierre Lavigne
Apr 15, 2008·Peptides·Luis de Lecea, Patrice Bourgin
Apr 12, 2008·Peptides·Caroline ParmentierHervé Tostivint
Feb 26, 2008·Peptides·Jean-Claude do RegoJean Costentin
Oct 13, 2007·Peptides·Jérôme LeprinceHubert Vaudry
Nov 11, 2005·The FEBS Journal·Hans-Peter Nothacker, Stewart Clark
Jul 17, 2010·Annals of the New York Academy of Sciences·Hubert VaudryJérôme Leprince
Dec 20, 2005·Journal of Chemical Neuroanatomy·Johann-Günther EggingerAndré Calas
Feb 7, 2006·General and Comparative Endocrinology·Stephen D McCormick, Don Bradshaw
Jan 25, 2006·The Journal of Comparative Neurology·Sylvie JégouIsabelle Lihrmann
Nov 11, 2005·Journal of Medicinal Chemistry·Paolo GriecoEttore Novellino
Nov 18, 2005·General and Comparative Endocrinology·Don Bradshaw, Stephen McCormick

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.